Vera Therapeutics, Inc.
VERA
$21.71
-$0.32-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 2.24% | 64.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.93% | -1.78% | |||
| Operating Income | -16.93% | 1.78% | |||
| Income Before Tax | -19.04% | 6.88% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -19.04% | 6.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -19.04% | 6.88% | |||
| EBIT | -16.93% | 1.78% | |||
| EBITDA | -16.89% | 1.84% | |||
| EPS Basic | -13.47% | 15.76% | |||
| Normalized Basic EPS | -13.46% | 15.77% | |||
| EPS Diluted | -13.47% | 15.76% | |||
| Normalized Diluted EPS | -13.46% | 15.77% | |||
| Average Basic Shares Outstanding | 4.91% | 10.56% | |||
| Average Diluted Shares Outstanding | 4.91% | 10.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||